The abstract is read at the publisher; the summary is JClub's.
Smart insulin pens with an integrated bolus calculator improved HbA1c more than tracking-only connected insulin pens over 12 weeks in adults with type 1 or type 2 diabetes on MDI.
- Why it matters: Connected insulin pens may help MDI users, but the incremental value of adding a bolus calculator for glycaemic control and safe insulin dosing was unclear.
- What they did: In a multicentre, open-label randomised controlled trial in nine South Korean centres, adults aged 19–74 with HbA1c 58–108 mmol/mol were assigned to smart insulin pens with bolus calculator or tracking-only CIPs for 12 weeks, using CGM throughout.
- The result: HbA1c fell more with smart pens (adjusted mean difference -3.39 mmol/mol; p=0.036), time in range increased (adjusted difference 6.58%; p=0.012), and missed bolus doses were lower (3.4 vs 3.7 times/day; p=0.020), with no severe hypoglycaemia or diabetic ketoacidosis in either group.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.